feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC
AArphra

BIO

Bio-Rad Laboratories, Inc.
HealthcareMedical - DevicesUSUSD
$305.46
LiveJun 01, 2026
AI Brief
Market cap
$8.26B
52w range
211.43 – 343.12
P / E
EPS
Volume
369.62K
Revenue · FY
$2.58B
+0.65% YoY

Explain this page

Arphra AI

AI Issuer Brief

Arphra AI
Loading cached brief…

Insider · 30d

Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Full history →

Price

DB · prices_daily
No price history in prices_daily for BIO.

Peers

No peer list available for BIO.

Price change · trailing returns

Live
1D5D1M3M6MYTD1Y3Y5Y10YMax
-2.25%+2.16%+19.06%+9.70%-4.99%+0.82%+41.05%-17.75%-47.47%+104.81%+11896.25%

Aftermarket

Live
Jun 01, 09:34 PM
Last trade
$305.46
658 sh
Bid
$271.34
5 sh
Ask
$325.00
2 sh
Spread
$53.660

Sector & industry today

Live
Sectors
  • Technology
    +3.30%
  • Basic Materials
    +0.98%
  • Energy
    +0.83%
  • Consumer Cyclical
    +0.49%
  • Industrials
    +0.25%
  • Communication Services
    +0.13%
  • Healthcare
    -0.65%
  • Financial Services
    -0.80%
  • Consumer Defensive
    -0.84%
  • Utilities
    -1.15%
  • Real Estate
    -1.32%
Top industries (issuer's industry highlighted)
  • Medical - Devices
    -0.34%
  • Computer Hardware
    +8.35%
  • Software - Infrastructure
    +7.61%
  • Consulting Services
    +5.28%
  • Coal
    +5.20%
  • Manufacturing - Metal Fabrication
    +4.24%
  • Staffing & Employment Services
    +4.08%
  • Gambling, Resorts & Casinos
    +3.71%
  • Broadcasting
    +3.70%
  • Integrated Freight & Logistics
    +3.68%
  • REIT - Healthcare Facilities
    -3.49%
  • Software - Application
    +3.44%
Weighted blend
$580.32
+89.98% vs spot
Recommendation
Strong Buy
4 of 4 methods
Method spread
1bull3bear
±5% threshold
Analyst PT consensus: $321.67 (+5.31%)
Total assets
$10.58B
Total debt
$1.53B
Cash & equiv
$531.8M
Operating CF
$532.2M
Free cash flow
$374.6M
Buybacks
-$295.5M

Analyst view

Consensus target
No price-target data returned for this ticker.
Recent actions
000 hold
  • No recent grade actions.

Recent quarters

All financials →
PeriodRevenueNet incomeEPS
Q1 Mar 2026$592.1M-$527.1M$-19.55
Q4 Dec 2025$693.2M$720M$26.65
Q3 Sep 2025$653M-$341.9M$-12.70
Q2 Jun 2025$651.6M$317.8M$11.67
Q1 Mar 2025$585.4M$64M$2.29
Q4 Dec 2024$667.48M-$715.8M$-25.57

Recent insiders

All →
InsiderActionSharesValueDate
No open-market insider activity in the recent window.

Income statement · annual

5y
Open Financials →
PeriodRevenueOp incomeNet incomeEPSNet margin
FY 2025$2.58B$270.5M$759.9M$27.87+29.42%
FY 2024$2.57B$269M-$1.84B$-65.36-71.86%
FY 2023$2.67B$337.8M-$637.32M$-21.82-23.86%
FY 2022$2.8B$482.62M-$3.63B$-121.79-129.45%
FY 2021$2.92B$500.34M$4.25B$140.83+145.57%